Vysioneer is an oncology AI company. Our journey started from the belief that every tumor matters in curing cancer. Powered by our FDA-cleared AI platform, Vysioneer unlocks drug efficacy with lesion-level precision, empowering pharma and clinicians to find the right treatment for the right tumor at the right moment. Vysioneer is headquartered in Cambridge, MA.